123 related articles for article (PubMed ID: 24250722)
1. Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma.
Dai D; Xu W; Liu J; Zhu L; Zhu X; Ma X
Exp Ther Med; 2013 Dec; 6(6):1417-1422. PubMed ID: 24250722
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of licartin with repeated administration in treatment of HCC patients after liver transplantation].
Li J; Qin L; Ding EC; Shen J; Li JP
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2645-2649. PubMed ID: 30220152
[No Abstract] [Full Text] [Related]
3. Efficacy of licartin combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced primary liver cancer.
Jin J; Zhou T; Lou J; Yan S; Wu Y; Xie M; Wang W
J BUON; 2020; 25(6):2584-2591. PubMed ID: 33455100
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma.
Tang M; Li WL; Li JY; Lv J; Chen FK; Zhu JL; Liu PJ
Front Oncol; 2022; 12():993948. PubMed ID: 36994225
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.
Xu J; Shen ZY; Chen XG; Zhang Q; Bian HJ; Zhu P; Xu HY; Song F; Yang XM; Mi L; Zhao QC; Tian R; Feng Q; Zhang SH; Li Y; Jiang JL; Li L; Yu XL; Zhang Z; Chen ZN
Hepatology; 2007 Feb; 45(2):269-76. PubMed ID: 17256759
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
[TBL] [Abstract][Full Text] [Related]
8. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
Ma J; Wang JH
Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres
Sun J; Zhou G; Xie X; Gu W; Huang J; Zhu D; Hu W; Hou Q; Shi C; Li T; Zhang X; Ji W; Ying S; Peng Z; Zhou J; Yu Z; Ji J; Du H; Guo X; Fang J; Han J; Xu H; Sun Z; Yu W; Shao G; Wu X; Hu H; Li L; Zheng J; Luo J; Chen Y; Cao G; Hu T
Oncol Res; 2020 Feb; 28(1):75-94. PubMed ID: 31558180
[TBL] [Abstract][Full Text] [Related]
10. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.
Cohen MJ; Bloom AI; Barak O; Klimov A; Nesher T; Shouval D; Levi I; Shibolet O
World J Gastroenterol; 2013 Apr; 19(16):2521-8. PubMed ID: 23674854
[TBL] [Abstract][Full Text] [Related]
11. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Lin ZH; Li X; Hong YF; Ma XK; Wu DH; Huang M; Chen ZH; Chen J; Dong M; Wei L; Wang TT; Ruan DY; Lin ZX; Zhong X; Xing YF; Wen JY; Wu XY; Lin Q
Tumour Biol; 2016 Mar; 37(3):2951-9. PubMed ID: 26411670
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome.
Chen X; Wang P; Yang M; Zhou W; Chen J; Meng Z; Su S
J Tradit Chin Med; 2021 Feb; 41(1):157-166. PubMed ID: 33522209
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma.
Liu J; Xu J; Zhang W; Chen J; Zhou X; Li Z; Han X
Acad Radiol; 2020 May; 27(5):704-709. PubMed ID: 31375353
[TBL] [Abstract][Full Text] [Related]
15. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.
Huang JH; Gao F; Gu YK; Li WQ; Lu LW
World J Gastroenterol; 2007 Dec; 13(48):6593-7. PubMed ID: 18161933
[TBL] [Abstract][Full Text] [Related]
19. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
He Q; Lu WS; Liu Y; Guan YS; Kuang AR
World J Gastroenterol; 2013 Dec; 19(47):9104-10. PubMed ID: 24379637
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
Zhang H; Yang A; Zhang J
J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
